OQROGet OQRO Pro
Insider trade

CME Group (CME)Director sold ~$82K

Martin J Gepsman, Director at CME Group, sold ~$82K of CME Group shares.

~$82K
Approx. value · 300 sh @ $273.17
25K
Holds after · shares reported
Traded
May 15, 2025
Filed
May 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 10, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  2. Mar 13, 2025InsiderDirector sold ~$2.6M of CME shares in the open market
  3. Mar 14, 2025InsiderDirector sold ~$385K of CME shares in the open market
  4. Mar 26, 2025InsiderDirector purchased ~$3K of CME shares in the open market
  5. Apr 8, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  6. Apr 24, 2025Insider · 1 personInsiders: 2 sales (~$528K)
  7. Apr 25, 2025InsiderDirector sold ~$532K of CME shares in the open market
  8. Apr 29, 2025InsiderDirector sold ~$271K of CME shares in the open market
  9. May 5, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  10. May 12, 2025CongressDisclosed sale of CME — reported range $15,001 - $50,000
  11. May 15, 2025 · this disclosureInsiderDirector sold ~$82K of CME shares in the open market

What came next

  1. May 15, 2025InsiderDirector sold ~$818K of CME shares in the open market
  2. May 19, 2025InsiderDirector sold ~$295K of CME shares in the open market
  3. May 20, 2025InsiderOfficer sold ~$108K of CME shares in the open market
  4. May 21, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  5. May 22, 2025InsiderDirector sold ~$141K of CME shares in the open market
  6. Jun 10, 2025Insider · 1 personInsiders: 2 sales (~$133K)
  7. Jul 22, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  8. Aug 11, 2025CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  9. Aug 14, 2025CongressDisclosed partial sale of CME — reported range $1,001 - $15,000
  10. Aug 26, 2025Insider · 1 personInsiders: 2 sales (~$3.2M)
  11. Sep 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 9, 2025, Jack Tobin, the Managing Director and Chief Accounting Officer of CME Group Inc. (the Company) notified the Company of his decision to retire from the Company.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by Martin J Gepsman, Director

The full history of Martin J Gepsman, Director is on the profile page.

How this filing works

Other disclosures at CME Group

Everything OQRO holds on this company is on its CME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data